{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "30",
                "@timestamp": "2023-08-30T04:37:52.000052-04:00",
                "@year": "2023",
                "@month": "08"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2023",
                "@month": "09"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "Masahiro Tsuboi"},
                {"xocs:funding-agency-matched-string": "Roy S. Herbst"},
                {
                    "xocs:funding-agency-matched-string": "AstraZeneca",
                    "xocs:funding-agency": "AstraZeneca",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004325",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2023-07-01T07:54:29.710Z",
            "xocs:funding-text": "This study (NCT02511106) was funded by AstraZeneca and was designed by the sponsor in collaboration with the principal investigators (Yi-Long Wu, Masahiro Tsuboi, and Roy S. Herbst). Data were collected by the investigators and analyzed and interpreted jointly with the sponsor. The authors vouch for the completeness and accuracy of the data and the data analyses and adherence to the protocol. All authors were involved in manuscript preparation, with medical writing support funded by the sponsor; all the authors reviewed the manuscript, provided input, and approved the final version for submission. Thanks to all the patients and their families and the staff and investigators at all study sites. The authors acknowledge Liz Sainsbury, for her valuable contributions to the data analyses, and Laila Cancian, PhD, of Ashfield MedComms, an Inizio Company, for medical writing support that was funded by AstraZeneca in accordance with Good Publications Practice guidelines ( https://www.ismpp.org/gpp-2022 ).",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60033129",
                            "@country": "aus",
                            "city": "Melbourne",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Peter MacCallum Cancer Centre"}
                            ],
                            "affiliation-id": {
                                "@afid": "60033129",
                                "@dptid": "113657124"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-949106172-4a2da88e240ad26201f383148ef75c64-1",
                            "ce:source-text": "Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia",
                            "@dptid": "113657124"
                        },
                        "author": [{
                            "ce:given-name": "Thomas",
                            "preferred-name": {
                                "ce:given-name": "Thomas",
                                "ce:initials": "T.",
                                "ce:surname": "John",
                                "ce:indexed-name": "John T."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-f021e16bedb0aef36127dd617cc875cc-1",
                            "@seq": "1",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "M.B.B.S., PhD",
                            "ce:surname": "John",
                            "@auid": "8696243400",
                            "ce:indexed-name": "John T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Australia",
                            "@afid": "60026553",
                            "@country": "aus",
                            "city": "Melbourne",
                            "organization": [
                                {"$": "Sir Peter MacCallum Department of Oncology"},
                                {"$": "The University of Melbourne"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60026553"},
                                {"@afid": "60118918"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949106172-3933a50b4fcab424eee891fbab4bae95-1",
                            "ce:source-text": "Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia"
                        },
                        "author": [{
                            "ce:given-name": "Thomas",
                            "preferred-name": {
                                "ce:given-name": "Thomas",
                                "ce:initials": "T.",
                                "ce:surname": "John",
                                "ce:indexed-name": "John T."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-f021e16bedb0aef36127dd617cc875cc-1",
                            "@seq": "1",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "M.B.B.S., PhD",
                            "ce:surname": "John",
                            "@auid": "8696243400",
                            "ce:indexed-name": "John T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Germany",
                            "@afid": "112642958",
                            "@country": "deu",
                            "city": "Berlin",
                            "organization": {"$": "Klinik für Pneumologie - Evangelische Lungenklinik Berlin Buch"},
                            "affiliation-id": {"@afid": "112642958"},
                            "@affiliation-instance-id": "OB2BibRecID-949106172-5771582c4a46b863888ff03b6cb5961a-1",
                            "ce:source-text": "Klinik fur Pneumologie - Evangelische Lungenklinik Berlin Buch, Berlin, Germany"
                        },
                        "author": [{
                            "ce:given-name": "Christian",
                            "preferred-name": {
                                "ce:given-name": "Christian",
                                "ce:initials": "C.",
                                "ce:surname": "Grohé",
                                "ce:indexed-name": "Grohé C."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-b83e8a01929560ee903db7ed7c693abf-1",
                            "@seq": "2",
                            "ce:initials": "C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Grohé",
                            "@auid": "55981368600",
                            "ce:indexed-name": "Grohe C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60005247",
                            "@country": "usa",
                            "city": "Los Angeles",
                            "organization": {"$": "David Geffen School of Medicine at University of California Los Angeles"},
                            "affiliation-id": [
                                {"@afid": "60005247"},
                                {"@afid": "60027550"}
                            ],
                            "state": "CA",
                            "@affiliation-instance-id": "OB2BibRecID-949106172-7f4e59f1b4f358348b0af0ad914246c7-1",
                            "ce:source-text": "David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California"
                        },
                        "author": [{
                            "ce:given-name": "Jonathan W.",
                            "preferred-name": {
                                "ce:given-name": "Jonathan W.",
                                "ce:initials": "J.W.",
                                "ce:surname": "Goldman",
                                "ce:indexed-name": "Goldman J.W."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-e2ec0f54ca97fcfb7806dc7fa5054293-1",
                            "@seq": "3",
                            "ce:initials": "J.W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Goldman",
                            "@auid": "55218010300",
                            "ce:indexed-name": "Goldman J.W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "60027817",
                            "@country": "can",
                            "city": "Toronto",
                            "organization": [
                                {"$": "Department of Medical Oncology and Hematology"},
                                {"$": "University Health Network"},
                                {"$": "Princess Margaret Cancer Centre and the University of Toronto"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60027817",
                                    "@dptid": "104410590"
                                },
                                {"@afid": "60016849"},
                                {"@afid": "60014468"}
                            ],
                            "state": "ON",
                            "@affiliation-instance-id": "OB2BibRecID-949106172-95104982882f1a37da896dee9f783083-1",
                            "ce:source-text": "Department of Medical Oncology and Hematology, University Health Network, Princess Margaret Cancer Centre and the University of Toronto, Toronto, Ontario, Canada",
                            "@dptid": "104410590"
                        },
                        "author": [{
                            "ce:given-name": "Frances A.",
                            "preferred-name": {
                                "ce:given-name": "Frances A.",
                                "ce:initials": "F.A.",
                                "ce:surname": "Shepherd",
                                "ce:indexed-name": "Shepherd F.A."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-6fde1603206b19c7763f46a2398d03f4-1",
                            "@seq": "4",
                            "ce:initials": "F.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, FRCPC",
                            "ce:surname": "Shepherd",
                            "@auid": "7101805167",
                            "ce:indexed-name": "Shepherd F.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60030442",
                            "@country": "ita",
                            "city": "Milan",
                            "organization": [
                                {"$": "Thoracic Oncology Division"},
                                {"$": "European Institute of Oncology (IEO)"},
                                {"$": "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)"}
                            ],
                            "affiliation-id": {
                                "@afid": "60030442",
                                "@dptid": "104540496"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-949106172-4ee238a56dd8c7dbb623bf320054c375-1",
                            "ce:source-text": "Thoracic Oncology Division, European Institute of Oncology (IEO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy",
                            "@dptid": "104540496"
                        },
                        "author": [{
                            "ce:given-name": "Filippo",
                            "preferred-name": {
                                "ce:given-name": "Filippo",
                                "ce:initials": "F.",
                                "ce:surname": "de Marinis",
                                "ce:indexed-name": "de Marinis F."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-98aa2f9f34be24ce600f11028edbde6b-1",
                            "@seq": "5",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "de Marinis",
                            "@auid": "56273853600",
                            "ce:indexed-name": "de Marinis F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Japan",
                            "@afid": "60017631",
                            "@country": "jpn",
                            "city": "Yokohama",
                            "organization": [
                                {"$": "Department of Thoracic Oncology"},
                                {"$": "Kanagawa Cancer Center"},
                                {"$": "Asahi Ward"}
                            ],
                            "affiliation-id": {
                                "@afid": "60017631",
                                "@dptid": "103910366"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-949106172-7d4021a86930257c0bd5834f6bdbd162-1",
                            "ce:source-text": "Department of Thoracic Oncology, Kanagawa Cancer Center, Asahi Ward, Yokohama, Japan",
                            "@dptid": "103910366"
                        },
                        "author": [{
                            "ce:given-name": "Terufumi",
                            "preferred-name": {
                                "ce:given-name": "Terufumi",
                                "ce:initials": "T.",
                                "ce:surname": "Kato",
                                "ce:indexed-name": "Kato T."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-b31f4d04d8704d8cb99ff2151d1ff49f-1",
                            "@seq": "6",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Kato",
                            "@auid": "35782069000",
                            "ce:indexed-name": "Kato T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60009860",
                            "@country": "chn",
                            "city": "Shanghai",
                            "organization": [
                                {"$": "Department of Thoracic Surgery"},
                                {"$": "Zhongshan Hospital"},
                                {"$": "Fudan University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60009860",
                                    "@dptid": "112869461"
                                },
                                {"@afid": "60073655"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949106172-d94597521d5a1bed2564d876f68ca2f4-1",
                            "ce:source-text": "Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China",
                            "@dptid": "112869461"
                        },
                        "author": [{
                            "ce:given-name": "Qun",
                            "preferred-name": {
                                "ce:given-name": "Qun",
                                "ce:initials": "Q.",
                                "ce:surname": "Wang",
                                "ce:indexed-name": "Wang Q."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-e02681d844131fd9b149233d198dc7cc-1",
                            "@seq": "7",
                            "ce:initials": "Q.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Wang",
                            "@auid": "57003969300",
                            "ce:indexed-name": "Wang Q."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Taiwan",
                            "@afid": "60014982",
                            "@country": "twn",
                            "city": "Tainan",
                            "organization": [
                                {"$": "Department of Oncology"},
                                {"$": "National Cheng Kung University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60014982",
                                "@dptid": "122810750"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-949106172-2e79568d6959efdd1e584e496a82ccd6-1",
                            "ce:source-text": "Department of Oncology, National Cheng Kung University, Tainan, Taiwan",
                            "@dptid": "122810750"
                        },
                        "author": [{
                            "ce:given-name": "Wu-Chou",
                            "preferred-name": {
                                "ce:given-name": "Wu Chou",
                                "ce:initials": "W.C.",
                                "ce:surname": "Su",
                                "ce:indexed-name": "Su W.C."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-fae27ae37b2f32bbbbf9b273ccb2ca01-1",
                            "@seq": "8",
                            "ce:initials": "W.-C.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Su",
                            "@auid": "57220849247",
                            "ce:indexed-name": "Su W.-C."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60029305",
                            "@country": "kor",
                            "city": "Suwon",
                            "organization": [
                                {"$": "Department of Hematology-Oncology"},
                                {"$": "Ajou University School of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "60029305",
                                "@dptid": "113150730"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-949106172-60d92b0a1a6d5c61dde76027051fe3f0-1",
                            "ce:source-text": "Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Republic of Korea",
                            "@dptid": "113150730"
                        },
                        "author": [{
                            "ce:given-name": "Jin Hyuk",
                            "preferred-name": {
                                "ce:given-name": "Jin Hyuk",
                                "ce:initials": "J.H.",
                                "ce:surname": "Choi",
                                "ce:indexed-name": "Choi J.H."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-c193718b2df9c3e8ea5a6959bc007357-1",
                            "@seq": "9",
                            "ce:initials": "J.H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Choi",
                            "@auid": "58399117800",
                            "ce:indexed-name": "Choi J.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and the King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "113628696"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949106172-0de60740d99c6cd2763e69c9368c0ea6-1",
                            "ce:source-text": "Division of Medical Oncology, Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "113628696"
                        },
                        "author": [{
                            "ce:given-name": "Virote",
                            "preferred-name": {
                                "ce:given-name": "Virote",
                                "ce:initials": "V.",
                                "ce:surname": "Sriuranpong",
                                "ce:indexed-name": "Sriuranpong V."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-fd898914cc0e36ede9b8d90068b05dff-1",
                            "@seq": "10",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Sriuranpong",
                            "@auid": "6603599644",
                            "ce:indexed-name": "Sriuranpong V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60024574",
                            "@country": "ita",
                            "city": "Bologna",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna"}
                            ],
                            "affiliation-id": {
                                "@afid": "60024574",
                                "@dptid": "126617346"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-949106172-80dcc539df40260ddef02f806ba0ea73-1",
                            "ce:source-text": "Division of Medical Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy",
                            "@dptid": "126617346"
                        },
                        "author": [{
                            "ce:given-name": "Barbara",
                            "preferred-name": {
                                "ce:given-name": "Barbara",
                                "ce:initials": "B.",
                                "ce:surname": "Melotti",
                                "ce:indexed-name": "Melotti B."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-d8f2a50c02e6f655fc20a3cdcb9cd422-1",
                            "@seq": "11",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Melotti",
                            "@auid": "6603480101",
                            "ce:indexed-name": "Melotti B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60018691",
                            "@country": "usa",
                            "city": "Chicago",
                            "organization": [
                                {"$": "Hematology"},
                                {"$": "Oncology and Cell Therapy"},
                                {"$": "Department of Medicine"},
                                {"$": "Rush University Medical Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60018691",
                                "@dptid": "109467629"
                            },
                            "state": "IL",
                            "@affiliation-instance-id": "OB2BibRecID-949106172-dc14da51cc316a4098f470f95c391c57-1",
                            "ce:source-text": "Hematology, Oncology and Cell Therapy, Department of Medicine, Rush University Medical Center, Chicago, Illinois",
                            "@dptid": "109467629"
                        },
                        "author": [{
                            "ce:given-name": "Mary J.",
                            "preferred-name": {
                                "ce:given-name": "Mary J.",
                                "ce:initials": "M.J.",
                                "ce:surname": "Fidler",
                                "ce:indexed-name": "Fidler M.J."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-744ef470af30fe662776b79639ab6115-1",
                            "@seq": "12",
                            "ce:initials": "M.J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Fidler",
                            "@auid": "24072857000",
                            "ce:indexed-name": "Fidler M.J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60011715",
                            "@country": "chn",
                            "city": "Tianjin",
                            "organization": [
                                {"$": "Department of Lung Cancer Surgery"},
                                {"$": "Tianjin Medical University General Hospital"}
                            ],
                            "affiliation-id": {
                                "@afid": "60011715",
                                "@dptid": "103626014"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-949106172-b5bb5cf73ad934425a6caa26c32b9b82-1",
                            "ce:source-text": "Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Tianjin, People's Republic of China",
                            "@dptid": "103626014"
                        },
                        "author": [{
                            "ce:given-name": "Jun",
                            "preferred-name": {
                                "ce:given-name": "Jun",
                                "ce:initials": "J.",
                                "ce:surname": "Chen",
                                "ce:indexed-name": "Chen J."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-c232ccb748ec3253021e1723e3d0a746-1",
                            "@seq": "13",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Chen",
                            "@auid": "56214794800",
                            "ce:indexed-name": "Chen J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United Kingdom",
                            "@afid": "60004219",
                            "@country": "gbr",
                            "city": "Cambridge",
                            "organization": [
                                {"$": "Oncology Research & Development"},
                                {"$": "AstraZeneca"}
                            ],
                            "affiliation-id": {"@afid": "60004219"},
                            "@affiliation-instance-id": "OB2BibRecID-949106172-ece724835073a2b3e6e1379dd6ab6560-1",
                            "ce:source-text": "Oncology Research & Development, AstraZeneca, Cambridge, United Kingdom"
                        },
                        "author": [{
                            "ce:given-name": "Muna",
                            "preferred-name": {
                                "ce:given-name": "Muna",
                                "ce:initials": "M.",
                                "ce:surname": "Albayaty",
                                "ce:indexed-name": "Albayaty M."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-d0166f7dc8b9cc090a3416e41b50aa50-1",
                            "@seq": "14",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MbChB., FFPM, MSc",
                            "ce:surname": "Albayaty",
                            "@auid": "55779423400",
                            "ce:indexed-name": "Albayaty M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Poland",
                            "@afid": "60004219",
                            "@country": "pol",
                            "city": "Warsaw",
                            "organization": [
                                {"$": "Late Oncology Research & Development"},
                                {"$": "AstraZeneca"}
                            ],
                            "affiliation-id": {"@afid": "60004219"},
                            "@affiliation-instance-id": "OB2BibRecID-949106172-55fc665e82d53a24f1c4dd3464a5cd82-1",
                            "ce:source-text": "Late Oncology Research & Development, AstraZeneca, Warsaw, Poland"
                        },
                        "author": [{
                            "ce:given-name": "Marta",
                            "preferred-name": {
                                "ce:given-name": "Marta",
                                "ce:initials": "M.",
                                "ce:surname": "Stachowiak",
                                "ce:indexed-name": "Stachowiak M."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-07eef84501b344d6a49c909c276b5e3a-1",
                            "@seq": "15",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MPharm",
                            "ce:surname": "Stachowiak",
                            "@auid": "58165178800",
                            "ce:indexed-name": "Stachowiak M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United Kingdom",
                            "@afid": "60004219",
                            "@country": "gbr",
                            "city": "Cambridge",
                            "organization": [
                                {"$": "Oncology Biometrics"},
                                {"$": "AstraZeneca"}
                            ],
                            "affiliation-id": {"@afid": "60004219"},
                            "@affiliation-instance-id": "OB2BibRecID-949106172-71a7f897bd4a038c34a0dce6f411e010-1",
                            "ce:source-text": "Oncology Biometrics, AstraZeneca, Cambridge, United Kingdom"
                        },
                        "author": [{
                            "ce:given-name": "Sarah",
                            "preferred-name": {
                                "ce:given-name": "Sarah",
                                "ce:initials": "S.",
                                "ce:surname": "Taggart",
                                "ce:indexed-name": "Taggart S."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-38d43f456714afd436886dd6acb4bddb-1",
                            "@seq": "16",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "Msci",
                            "ce:surname": "Taggart",
                            "@auid": "58393645600",
                            "ce:indexed-name": "Taggart S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "China",
                            "@afid": "60069718",
                            "@country": "chn",
                            "city": "Guangzhou",
                            "organization": [
                                {"$": "Guangdong Lung Cancer Institute"},
                                {"$": "Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences)"},
                                {"$": "Southern Medical University"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60069718"},
                                {"@afid": "60002593"}
                            ],
                            "@affiliation-instance-id": "OB2BibRecID-949106172-47b4206bda7c7c4fb9b52fa22ff621d2-1",
                            "ce:source-text": "Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, People's Republic of China"
                        },
                        "author": [{
                            "ce:given-name": "Yi-Long",
                            "preferred-name": {
                                "ce:given-name": "Yi Long",
                                "ce:initials": "Y.L.",
                                "ce:surname": "Wu",
                                "ce:indexed-name": "Wu Y.L."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-224034ea062e131f02753dac33d96456-1",
                            "@seq": "17",
                            "ce:initials": "Y.-L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Wu",
                            "@auid": "55569782000",
                            "ce:indexed-name": "Wu Y.-L."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Japan",
                            "@afid": "60010925",
                            "@country": "jpn",
                            "city": "Kashiwa",
                            "organization": [
                                {"$": "Department of Thoracic Surgery and Oncology"},
                                {"$": "National Cancer Center Hospital East"}
                            ],
                            "affiliation-id": {
                                "@afid": "60010925",
                                "@dptid": "107946452"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-949106172-18b4427e6f2a836fa08fbf61aed03d2c-1",
                            "ce:source-text": "Department of Thoracic Surgery and Oncology, National Cancer Center Hospital East, Kashiwa, Japan",
                            "@dptid": "107946452"
                        },
                        "author": [{
                            "ce:given-name": "Masahiro",
                            "preferred-name": {
                                "ce:given-name": "Masahiro",
                                "ce:initials": "M.",
                                "ce:surname": "Tsuboi",
                                "ce:indexed-name": "Tsuboi M."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-de1a43293e2cdd36efeb22335cb066e9-1",
                            "@seq": "18",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Tsuboi",
                            "@auid": "55450411000",
                            "ce:indexed-name": "Tsuboi M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60017994",
                            "@country": "usa",
                            "city": "New Haven",
                            "organization": [
                                {"$": "Medical Oncology"},
                                {"$": "Yale School of Medicine and Yale Cancer Center"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60017994"},
                                {"@afid": "60030849"}
                            ],
                            "state": "CT",
                            "@affiliation-instance-id": "OB2BibRecID-949106172-da3d4e1a87bfe9f17b0a9a5e0225c25d-1",
                            "ce:source-text": "Medical Oncology, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut"
                        },
                        "author": [{
                            "ce:given-name": "Roy S.",
                            "preferred-name": {
                                "ce:given-name": "Roy S.",
                                "ce:initials": "R.S.",
                                "ce:surname": "Herbst",
                                "ce:indexed-name": "Herbst R.S."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-88f61568d504436f7320f7b5dec2cf87-1",
                            "@seq": "19",
                            "ce:initials": "R.S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Herbst",
                            "@auid": "7102823077",
                            "ce:indexed-name": "Herbst R.S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Spain",
                            "@afid": "60009466",
                            "@country": "esp",
                            "city": "Barcelona",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Hospital de la Santa Creu i Sant Pau"}
                            ],
                            "affiliation-id": {
                                "@afid": "60009466",
                                "@dptid": "112899666"
                            },
                            "@affiliation-instance-id": "OB2BibRecID-949106172-0769d872b2ce25258d01aed9e8c8e019-1",
                            "ce:source-text": "Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain",
                            "@dptid": "112899666"
                        },
                        "author": [{
                            "ce:given-name": "Margarita",
                            "preferred-name": {
                                "ce:given-name": "Margarita",
                                "ce:initials": "M.",
                                "ce:surname": "Majem",
                                "ce:indexed-name": "Majem M."
                            },
                            "@author-instance-id": "OB2BibRecID-949106172-8b0a132f33550b85f7fa76c2421b2d02-1",
                            "@seq": "20",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Majem",
                            "@auid": "24587678300",
                            "ce:indexed-name": "Majem M."
                        }]
                    }
                ],
                "citation-title": "Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial",
                "abstracts": "© 2023 International Association for the Study of Lung CancerIntroduction: In ADAURA, adjuvant osimertinib significantly improved disease-free survival versus placebo in resected stage IB to IIIA EGFR-mutated NSCLC. We report in-depth analyses of three-year safety, tolerability, and health-related quality of life (HRQoL) from ADAURA. Methods: Patients were randomized 1:1 to osimertinib 80 mg or placebo once daily for up to 3 years. Safety assessments were performed at baseline, week 2, week 4, week 12, and every 12 weeks until treatment completion or discontinuation, and 28 days after treatment was stopped. The SF-36 survey measured HRQoL at baseline, week 12, week 24, and every 24 weeks until recurrence, treatment completion or discontinuation. Data cutoff: April 11, 2022. Results: Safety and HRQoL analysis sets: osimertinib, n = 337 and n = 339; placebo, n = 343 each. Median (range) total exposure duration was longer with osimertinib versus placebo: 35.8 (0\u201338) versus 25.1 (0\u201339) months. Most adverse events (AEs) were first reported within 12 months of starting treatment (osimertinib 97%, placebo 86%). AEs leading to dose reduction, interruption or discontinuation were reported in 12%, 27% and 13% respectively of patients with osimertinib; 1%, 13% and 3% with placebo. Stomatitis and diarrhea were the most common AEs leading to osimertinib dose reduction or interruption; interstitial lung disease was the most common leading to osimertinib discontinuation (per protocol). There were no differences in time to deterioration for SF-36 physical, mental component summaries between osimertinib and placebo. Conclusions: No new safety signals were reported and HRQoL was maintained with 3 years of adjuvant osimertinib treatment. Combined with significant efficacy benefit, these data further support adjuvant osimertinib in stage IB to IIIA EGFR-mutated NSCLC.",
                "correspondence": {
                    "affiliation": {
                        "country": "Australia",
                        "address-part": "305 Grattan Street",
                        "postal-code": "3000",
                        "@country": "aus",
                        "city": "Melbourne",
                        "organization": [
                            {"$": "Department of Medical Oncology"},
                            {"$": "Peter MacCallum Cancer Centre"}
                        ],
                        "state": "VIC",
                        "@affiliation-instance-id": "OB2BibRecID-949106172-81602e7f829b3e9b6bfbcc9e51c907e1-1"
                    },
                    "person": {
                        "ce:given-name": "Thomas",
                        "@author-instance-id": "OB2BibRecID-949106172-6518ae9485ded60a43536e34d79768b4-1",
                        "ce:initials": "T.",
                        "ce:degrees": "M.B.B.S., PhD",
                        "ce:surname": "John",
                        "ce:indexed-name": "John T."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Adjuvant",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "EGFR",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Non\u2013small cell lung cancer",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Osimertinib",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Safety",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "J. Thorac. Oncol.",
                    "website": {"ce:e-address": {
                        "$": "https://www.journals.elsevier.com/journal-of-thoracic-oncology/",
                        "@type": "email"
                    }},
                    "@country": "usa",
                    "translated-sourcetitle": {
                        "$": "Journal of Thoracic Oncology",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "15561380",
                            "@type": "electronic"
                        },
                        {
                            "$": "15560864",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "18",
                            "@issue": "9"
                        },
                        "pagerange": {
                            "@first": "1209",
                            "@last": "1221"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2023"},
                    "publisher": {"publishername": "Elsevier Inc."},
                    "sourcetitle": "Journal of Thoracic Oncology",
                    "@srcid": "6400153137",
                    "publicationdate": {
                        "month": "09",
                        "year": "2023",
                        "date-text": "September 2023",
                        "day": "01"
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2730"},
                                {"$": "2740"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": "79079-06-4",
                                    "chemical-name": "epidermal growth factor receptor"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "1421373-65-0"},
                                        {"$": "1421373-66-1"}
                                    ],
                                    "chemical-name": "osimertinib"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Aniline Compounds"},
                                {"chemical-name": "EGFR protein, human"},
                                {"chemical-name": "ErbB Receptors"},
                                {"chemical-name": "osimertinib"},
                                {"chemical-name": "Protein Kinase Inhibitors"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "Disclosure: Dr. John reports having consulting or advisory roles for Amgen (institution), AstraZeneca, AstraZeneca/MedImmune, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences Ignyta, Pfizer, Merck KGaA, Merck Sharp & Dohme Oncology, Novartis, PharmaMar (institution), Roche/Genentech, and Specialised Therapeutics; receiving honoraria from AstraZeneca/MedImmune, Bristol-Myers Squibb, Merck Sharp & Dohme Oncology, and Roche/Genentech; and receiving travel support from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck Sharp & Dohme, and Roche. Dr. Grohé reports having consulting or advisory roles for AstraZeneca, Boehringer Ingelheim, and Merck Sharp & Dohme; receiving travel fees from Boehringer Ingelheim; and serving on the speaker bureau of AstraZeneca, Boehringer Ingelheim, and Merck Sharp & Dohme. Dr. Goldman reports receiving research support from Advaxis, Array, AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Company, Genentech, G1 Therapeutics, Merck, and Pfizer travel fees from AstraZeneca; and honoraria from AstraZeneca, Bristol-Myers Squibb, Genentech, and Pfizer. Dr. Shepherd reports having consulting or advisory roles for AstraZeneca and Merck Serono; receiving honoraria from AstraZeneca, AstraZeneca/MedImmune (inst), Daiichi Sankyo, Merck Serono, and Takeda; receiving research funding from Lilly (inst), Pfizer (inst), Bristol-Myers Squibb (inst), and Roche Canada (inst); and owning AstraZeneca and Eli Lilly stocks. Dr. de Marinis reports serving on the speaker bureau of AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Takeda, and X-Covery. Dr. Kato reports having consulting or advisory roles for Amgen Inc., AstraZeneca, Chugai Pharmaceuticals Co., Ltd., Daiichi Sankyo, Eli Lilly and Company, Merck Serono, Merck Sharp & Dohme, and Pfizer; serving on the speaker bureau of Amgen Inc., AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai Pharmaceutical Co., Ltd., Eli Lilly and Company, Merck Serono, Merck Sharp & Dohme, Novartis, Pfizer, Roche, and Taiho Pharmaceutical; having a family member (spouse) who is an employee of Eli Lilly and company; and receiving research support from AbbVie Inc., Amgen Inc., AstraZeneca, Chugai Pharmaceutical, Eli Lilly and Company, Merck Serono, Merck Sharp & Dohme, Novartis, Pfizer, and Regeneron Pharmaceuticals. Dr. Su reports having consulting or advisory roles for Bayer Schering Pharma, Eli Lilly and Company, Merck, and Merck Sharp & Dohme Oncology. Dr. Choi reports receiving grants/contracts from AstraZeneca, Roche, Samyang Holdings, and Yuhan. Dr. Sriuranpong reports having consulting or advisory roles for Astellas, AstraZeneca, Merck Sharp & Dohme, Roche, and Novartis; and receiving research support from Astellas, AstraZeneca, Daiichi Sankyo, Merck Sharp & Dohme, Novartis, Roche, and Takeda. Dr. Melotti reports having consulting or advisory roles for AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Roche, Sanofi, and Sun Pharmaceutical Industries, Ltd.; being an invited speaker for AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Roche, Sanofi, and Sun Pharmaceutical Industries Ltd.; and being a principal investigator for AstraZeneca, Bristol-Myers Squibb, Novartis, Roche, and Sanofi. Dr. Fidler reports having consulting or advisory roles for AstraZeneca, BeiGene, Biodesix, Daiichi Sankyo, G1 Therapeutics, Genentech, Gilead, Janssen, Jazz Pharmaceuticals, Rakuten, Regeneron, Sanofi, Silverback Therapeutics, and Takeda; and receiving research support from Alkermes, Astellas, AstraZeneca, Biodesix, Genentech, Gilead, Pfizer, and Rakuten. Dr. Albayaty and Ms. Stachowiak report employment with AstraZeneca. Ms. Taggart reports employment with AstraZeneca (contracted) and Exploristics. Dr. Wu reports having consulting or advisory roles for AstraZeneca, Boehringer Ingelheim, Novartis, and Takeda; receiving research support from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Hengrui, and Roche; and receiving honoraria from AstraZeneca, BeiGene, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, Merck Sharp & Dohme, Pfizer, Roche, and Sanofi. Dr. Tsuboi reports having consulting or advisory roles for AstraZeneca KK, Chugai Pharmaceutical Co. Ltd., Merck Sharp & Dohme, and Novartis; receiving research support from AstraZeneca KK, Boehringer Ingelheim Japan, Bristol-Myers Squibb KK, Merck Sharp & Dohme, MiRXES, Novartis, and Ono Pharmaceuticals Co. Ltd.; and receiving honoraria from AstraZeneca KK, Bristol-Myers Squibb KK, Chugai Pharmaceutical Co. Ltd., Eli Lilly Japan, Johnson & Johnson Japan, Medtronic Japan Co., Ltd., Merck Sharp & Dohme, Novartis, Ono Pharmaceuticals Co. Ltd., and Taiho Pharma. Dr. Herbst reports having consulting or advisory roles for AstraZeneca, Bolt Biotherapeutics, Bristol-Myers Squibb, Candel Therapeutics, Inc., Checkpoint Therapeutics, Cybrexa Therapeutics, DynamiCure Biotechnology, LLC, eFFECTOR Therapeutics, Inc., Eli Lilly and Company, EMD Serono, Genentech, Gilead, HiberCell, Inc., I-Mab Biopharma, Immune-Onc Therapeutics, Inc., Immunocore, Janssen, Johnson & Johnson, Loxo Oncology, Mirati Therapeutics, NextCure, Novartis, Ocean Biomedical, Inc., Oncocyte Corp., Oncternal Therapeutics, Pfizer, Regeneron Pharmaceuticals Inc., Revelar Biotherapeutics, Inc., Ribbon Therapeutics, Roche, Sanofi, and Xencor, Inc.; receiving research support from AstraZeneca, Eli Lilly and Company, Genentech, and Merck Sharp & Dohme; having leadership roles for the American Association for Cancer Research, International Association for the Study of Lung Cancer, Society for Immunotherapy of Cancer, Southwest Oncology Group; and having served as board member (non-executive/independent) for Immunocore and Junshi Pharmaceuticals. Dr. Majem reports having consulting or advisory roles for Amgen Inc., AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Merck Sharp & Dohme, Novartis, Roche, and Sanofi; receiving research support from AstraZeneca, Bristol-Myers Squibb, and Roche; and receiving honoraria from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Kyowa Kyrin, Merck Sharp & Dohme, Novartis, Pierre Fabre, Roche, and Takeda. Drs. Wang and Chen declare no conflict of interest.This study (NCT02511106) was funded by AstraZeneca and was designed by the sponsor in collaboration with the principal investigators (Yi-Long Wu, Masahiro Tsuboi, and Roy S. Herbst). Data were collected by the investigators and analyzed and interpreted jointly with the sponsor. The authors vouch for the completeness and accuracy of the data and the data analyses and adherence to the protocol. All authors were involved in manuscript preparation, with medical writing support funded by the sponsor; all the authors reviewed the manuscript, provided input, and approved the final version for submission. Thanks to all the patients and their families and the staff and investigators at all study sites. The authors acknowledge Liz Sainsbury, for her valuable contributions to the data analyses, and Laila Cancian, PhD, of Ashfield MedComms, an Inizio Company, for medical writing support that was funded by AstraZeneca in accordance with Good Publications Practice guidelines (https://www.ismpp.org/gpp-2022). Data underlying the findings described in this manuscript may be obtained in accordance with AstraZeneca's data-sharing policy described at https://astrazenecagrouptrials.pharmacm.com/ST/Submission/Disclosure.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-acronym": "Abbvie",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "AbbVie"
                            },
                            "grant-agency-id": "100006483"
                        },
                        {
                            "grant-acronym": "Array",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Array BioPharma"
                            },
                            "grant-agency-id": "100007174"
                        },
                        {
                            "grant-acronym": "Astellas",
                            "grant-agency": {
                                "@iso-code": "can",
                                "$": "Astellas Pharma Canada"
                            },
                            "grant-agency-id": "100012317"
                        },
                        {
                            "grant-acronym": "Astellas",
                            "grant-agency": {
                                "@iso-code": "can",
                                "$": "Astellas Pharma Canada"
                            },
                            "grant-agency-id": "100012317"
                        },
                        {
                            "grant-acronym": "BMS",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Bristol-Myers Squibb"
                            },
                            "grant-agency-id": "100002491"
                        },
                        {
                            "grant-acronym": "Chugai",
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Chugai Pharmaceutical"
                            },
                            "grant-agency-id": "100010795"
                        },
                        {
                            "grant-acronym": "DSE",
                            "grant-agency": {
                                "@iso-code": "deu",
                                "$": "Daiichi Sankyo Europe"
                            },
                            "grant-agency-id": "501100022274"
                        },
                        {
                            "grant-acronym": "Gilead",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Gilead UK and Ireland Corporate Contributions"
                            },
                            "grant-agency-id": "100016016"
                        },
                        {
                            "grant-acronym": "Lilly",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Eli Lilly and Company"
                            },
                            "grant-agency-id": "100004312"
                        },
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "irl",
                                "$": "Alkermes"
                            },
                            "grant-agency-id": "100018529"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "deu",
                                "$": "Boehringer Ingelheim"
                            },
                            "grant-agency-id": "100008349"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "jpn",
                                "$": "Boehringer Ingelheim Japan"
                            },
                            "grant-agency-id": "100017346"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Genentech"
                            },
                            "grant-agency-id": "100004328"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Regeneron Pharmaceuticals"
                            },
                            "grant-agency-id": "100009857"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "kor",
                                "$": "Yuhan"
                            },
                            "grant-agency-id": "100019265"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2023 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "26",
                    "@timestamp": "BST 08:04:24",
                    "@year": "2023",
                    "@month": "08"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2025206214",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "641429259",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "949106172",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20230607094",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "37236398",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20231815367",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20232408299",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85163304152",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85163304152",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "641429259",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "78898199",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S1556086423005749",
                    "ce:ern": "pii:S1556086423005749",
                    "ce:doi": "10.1016/j.jtho.2023.05.015"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "25",
                "reference": [
                    {
                        "ref-fulltext": "Cross, D.A., Ashton, S.E., Ghiorghiu, S., et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov 4 (2014), 1046\u20131061.",
                        "@reference-instance-id": "OB2BibRecID-949106172-c1a49862f150009113b8167712d3410d-1",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84904898065",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {
                                    "@first": "1046",
                                    "@last": "1061"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Cross",
                                        "ce:indexed-name": "Cross D.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Ashton",
                                        "ce:indexed-name": "Ashton S.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ghiorghiu",
                                        "ce:indexed-name": "Ghiorghiu S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Discov"
                        },
                        "ce:source-text": "Cross DA, Ashton SE, Ghiorghiu S, et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov. 2014;4:1046-1061."
                    },
                    {
                        "ref-fulltext": "Mok, T.S., Wu, Y.L., Ahn, M.J., et al. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. N Engl J Med 376 (2017), 629\u2013640.",
                        "@reference-instance-id": "OB2BibRecID-949106172-5d0f10ba1e80190b3ce0731873e92100-2",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85013382512",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "376"},
                                "pagerange": {
                                    "@first": "629",
                                    "@last": "640"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu Y.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ahn",
                                        "ce:indexed-name": "Ahn M.J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Mok TS, Wu YL, Ahn MJ, et al. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. N Engl J Med. 2017;376:629-640."
                    },
                    {
                        "ref-fulltext": "Ramalingam, S.S., Vansteenkiste, J., Planchard, D., et al. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N Engl J Med 382 (2020), 41\u201350.",
                        "@reference-instance-id": "OB2BibRecID-949106172-dbf60466b25bcf846980dce0f73adac8-3",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85077224130",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "382"},
                                "pagerange": {
                                    "@first": "41",
                                    "@last": "50"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Ramalingam",
                                        "ce:indexed-name": "Ramalingam S.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Vansteenkiste",
                                        "ce:indexed-name": "Vansteenkiste J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Planchard",
                                        "ce:indexed-name": "Planchard D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Ramalingam SS, Vansteenkiste J, Planchard D, et al. Overall survival with osimertinib in untreated, EGFR-mutated advanced NSCLC. N Engl J Med. 2020;382:41-50."
                    },
                    {
                        "ref-fulltext": "Reungwetwattana, T., Nakagawa, K., Cho, B.C., et al. CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer. J Clin Oncol 36 (2018), 3290\u20133297.",
                        "@reference-instance-id": "OB2BibRecID-949106172-9282959fdf10e7c2202921a441fbe7c6-4",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85056728302",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "36"},
                                "pagerange": {
                                    "@first": "3290",
                                    "@last": "3297"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Reungwetwattana",
                                        "ce:indexed-name": "Reungwetwattana T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Nakagawa",
                                        "ce:indexed-name": "Nakagawa K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Cho",
                                        "ce:indexed-name": "Cho B.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Reungwetwattana T, Nakagawa K, Cho BC, et al. CNS response to osimertinib versus standard epidermal growth factor receptor tyrosine kinase inhibitors in patients with untreated EGFR-mutated advanced non-small-cell lung cancer [e-pub ahead of print]. J Clin Oncol. https://doi.org/10.1200/JCO.2018.78.3118, accessed XXX."
                    },
                    {
                        "ref-fulltext": "Wu, Y.L., Ahn, M.J., Garassino, M.C., et al. CNS efficacy of osimertinib in patients with T790M-positive advanced non-small-cell lung cancer: data from a randomized phase III trial (AURA3). J Clin Oncol 36 (2018), 2702\u20132709.",
                        "@reference-instance-id": "OB2BibRecID-949106172-573178ea0cef001429fdcded44989b83-5",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "CNS efficacy of osimertinib in patients with T790M-positive advanced non-small-cell lung cancer: data from a randomized phase III trial (AURA3)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85053005853",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "36"},
                                "pagerange": {
                                    "@first": "2702",
                                    "@last": "2709"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu Y.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ahn",
                                        "ce:indexed-name": "Ahn M.J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Garassino",
                                        "ce:indexed-name": "Garassino M.C."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Wu YL, Ahn MJ, Garassino MC, et al. CNS efficacy of osimertinib in patients with T790M-positive advanced non-small-cell lung cancer: data from a randomized phase III trial (AURA3). J Clin Oncol. 2018;36:2702-2709."
                    },
                    {
                        "ref-fulltext": "Remon, J., Soria, J.C., Peters, S., ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Early and locally advanced non-small-cell lung cancer: an update of the ESMO clinical practice guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol 32 (2021), 1637\u20131642.",
                        "@reference-instance-id": "OB2BibRecID-949106172-cd10b2056e01460637ecbec39d465b3e-6",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-website": {"ce:e-address": {
                                "$": "clinicalguidelines@esmo.org",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85116904774",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "32"},
                                "pagerange": {
                                    "@first": "1637",
                                    "@last": "1642"
                                }
                            },
                            "ref-text": "Electronic address:. Early and locally advanced non-small-cell lung cancer: an update of the ESMO clinical practice guidelines focusing on diagnosis, staging, systemic and local therapy.",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Remon",
                                        "ce:indexed-name": "Remon J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Soria",
                                        "ce:indexed-name": "Soria J.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Peters",
                                        "ce:indexed-name": "Peters S."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "ESMO Guidelines Committee",
                                    "ce:indexed-name": "ESMO Guidelines Committee"
                                }
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Remon J, Soria JC, Peters S, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Early and locally advanced non-small-cell lung cancer: an update of the ESMO clinical practice guidelines focusing on diagnosis, staging, systemic and local therapy. Ann Oncol. 2021;32:1637-1642."
                    },
                    {
                        "ref-fulltext": "Wu, Y.L., Tsuboi, M., He, J., et al. Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N Engl J Med 383 (2020), 1711\u20131723.",
                        "@reference-instance-id": "OB2BibRecID-949106172-561567e0b45fb5f4f243789f4e4fe309-7",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Osimertinib in resected EGFR-mutated non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85094933243",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "383"},
                                "pagerange": {
                                    "@first": "1711",
                                    "@last": "1723"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu Y.L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Tsuboi",
                                        "ce:indexed-name": "Tsuboi M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "He",
                                        "ce:indexed-name": "He J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Wu YL, Tsuboi M, He J, et al. Osimertinib in resected EGFR-mutated non-small-cell lung cancer. N Engl J Med. 2020;383:1711-1723."
                    },
                    {
                        "ref-fulltext": "Herbst, R.S., Wu, Y.-L., John, T., et al. Adjuvant osimertinib for resected EGFR-mutated stage IB\u2012IIIA NSCLC: updated results from the phase III randomized ADAURA trial. J Clin Oncol 41 (2023), 1830\u20131840.",
                        "@reference-instance-id": "OB2BibRecID-949106172-992b1793403bb2b13627a26ff554165a-8",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2023"},
                            "ref-title": {"ref-titletext": "Adjuvant osimertinib for resected EGFR-mutated stage IB\u2012IIIA NSCLC: updated results from the phase III randomized ADAURA trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85149687912",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "1830",
                                    "@last": "1840"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Herbst",
                                        "ce:indexed-name": "Herbst R.S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.-L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu Y.-L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "John",
                                        "ce:indexed-name": "John T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Herbst RS, Wu Y-L, John T, et al. Adjuvant osimertinib for resected EGFR-mutated stage IB-IIIA NSCLC: updated results from the phase III randomized ADAURA trial. J Clin Oncol. 2023;41:1830-1840."
                    },
                    {
                        "ref-fulltext": "Zhong, W.Z., Wang, Q., Mao, W.M., et al. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study. Lancet Oncol 19 (2018), 139\u2013148.",
                        "@reference-instance-id": "OB2BibRecID-949106172-58831d4942200d4fd5cfbe2a68a5feb9-9",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85034633134",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "139",
                                    "@last": "148"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.Z.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhong",
                                        "ce:indexed-name": "Zhong W.Z."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Q.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang Q."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Mao",
                                        "ce:indexed-name": "Mao W.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Zhong WZ, Wang Q, Mao WM, et al. Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study. Lancet Oncol. 2018;19:139-148."
                    },
                    {
                        "ref-fulltext": "Delaloge, S., Cella, D., Ye, Y., et al. Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial. Ann Oncol 30 (2019), 567\u2013574.",
                        "@reference-instance-id": "OB2BibRecID-949106172-af7b6cf3b8bc7f21c0bd79dc40cb964e-10",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85062243680",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "567",
                                    "@last": "574"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Delaloge",
                                        "ce:indexed-name": "Delaloge S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Cella",
                                        "ce:indexed-name": "Cella D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ye",
                                        "ce:indexed-name": "Ye Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Delaloge S, Cella D, Ye Y, et al. Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial. Ann Oncol. 2019;30:567-574."
                    },
                    {
                        "ref-fulltext": "Goss, P.E., Ingle, J.N., Pritchard, K.I., et al. Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med 375 (2016), 209\u2013219.",
                        "@reference-instance-id": "OB2BibRecID-949106172-fa532138b1b44229f0f9f822da93b23e-11",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Extending aromatase-inhibitor adjuvant therapy to 10 years"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84979701285",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "375"},
                                "pagerange": {
                                    "@first": "209",
                                    "@last": "219"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Goss",
                                        "ce:indexed-name": "Goss P.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Ingle",
                                        "ce:indexed-name": "Ingle J.N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Pritchard",
                                        "ce:indexed-name": "Pritchard K.I."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Goss PE, Ingle JN, Pritchard KI, et al. Extending aromatase-inhibitor adjuvant therapy to 10 years. N Engl J Med. 2016;375:209-219."
                    },
                    {
                        "ref-fulltext": "Boyle, F.M., Smith, I.E., O'Shaughnessy, J., et al. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human epidermal growth factor Receptor (HER2) overexpressing breast cancer. Eur J Cancer 51 (2015), 685\u2013696.",
                        "@reference-instance-id": "OB2BibRecID-949106172-1f27660a1e725f13da653bfbe1d88ab5-12",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human epidermal growth factor Receptor (HER2) overexpressing breast cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84925372286",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "51"},
                                "pagerange": {
                                    "@first": "685",
                                    "@last": "696"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Boyle",
                                        "ce:indexed-name": "Boyle F.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Smith",
                                        "ce:indexed-name": "Smith I.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "O'Shaughnessy",
                                        "ce:indexed-name": "O'Shaughnessy J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Boyle FM, Smith IE, O'Shaughnessy J, et al. Health related quality of life of women in TEACH, a randomised placebo controlled adjuvant trial of lapatinib in early stage Human epidermal growth factor Receptor (HER2) overexpressing breast cancer. Eur J Cancer. 2015;51:685-696."
                    },
                    {
                        "ref-fulltext": "Whelan, T.J., Goss, P.E., Ingle, J.N., et al. Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol 23 (2005), 6931\u20136940.",
                        "@reference-instance-id": "OB2BibRecID-949106172-1c17b76d7c49e3011b421adc1c158139-13",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "27244436756",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "23"},
                                "pagerange": {
                                    "@first": "6931",
                                    "@last": "6940"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.J.",
                                        "@_fa": "true",
                                        "ce:surname": "Whelan",
                                        "ce:indexed-name": "Whelan T.J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Goss",
                                        "ce:indexed-name": "Goss P.E."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.N.",
                                        "@_fa": "true",
                                        "ce:surname": "Ingle",
                                        "ce:indexed-name": "Ingle J.N."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Whelan TJ, Goss PE, Ingle JN, et al. Assessment of quality of life in MA.17: a randomized, placebo-controlled trial of letrozole after 5 years of tamoxifen in postmenopausal women. J Clin Oncol. 2005;23:6931-6940."
                    },
                    {
                        "ref-fulltext": "Lin, C., Hu, F., Chu, H., et al. The role of EGFR-TKIs as adjuvant therapy in EGFR mutation-positive early-stage NSCLC: a meta-analysis. Thorac Cancer 12 (2021), 1084\u20131095.",
                        "@reference-instance-id": "OB2BibRecID-949106172-e106a12c358078440587b21d9b5fbfd5-14",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "The role of EGFR-TKIs as adjuvant therapy in EGFR mutation-positive early-stage NSCLC: a meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85101917901",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "1084",
                                    "@last": "1095"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lin",
                                        "ce:indexed-name": "Lin C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Hu",
                                        "ce:indexed-name": "Hu F."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Chu",
                                        "ce:indexed-name": "Chu H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Thorac Cancer"
                        },
                        "ce:source-text": "Lin C, Hu F, Chu H, et al. The role of EGFR-TKIs as adjuvant therapy in EGFR mutation-positive early-stage NSCLC: a meta-analysis. Thorac Cancer. 2021;12:1084-1095."
                    },
                    {
                        "ref-fulltext": "Zhao, P., Zhen, H., Zhao, H., Zhao, L., Cao, B., Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials. BMC Cancer, 22, 2022, 328.",
                        "@reference-instance-id": "OB2BibRecID-949106172-ef96e373ffc6e34ca03e6ee304a72ff3-15",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85127268642",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {"@first": "328"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhao",
                                    "ce:indexed-name": "Zhao P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhen",
                                    "ce:indexed-name": "Zhen H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhao",
                                    "ce:indexed-name": "Zhao H."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "L.",
                                    "@_fa": "true",
                                    "ce:surname": "Zhao",
                                    "ce:indexed-name": "Zhao L."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Cao",
                                    "ce:indexed-name": "Cao B."
                                }
                            ]},
                            "ref-sourcetitle": "BMC Cancer"
                        },
                        "ce:source-text": "Zhao P, Zhen H, Zhao H, Zhao L, Cao B. Efficacy and safety of adjuvant EGFR-TKIs for resected non-small cell lung cancer: a systematic review and meta-analysis based on randomized control trials. BMC Cancer. 2022;22:328."
                    },
                    {
                        "ref-fulltext": "Papadimitrakopoulou, V.A., Mok, T.S., Han, J.Y., et al. Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. Ann Oncol 31 (2020), 1536\u20131544.",
                        "@reference-instance-id": "OB2BibRecID-949106172-ab05620c87d2f146561afd92f7dbf777-16",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85091610802",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "1536",
                                    "@last": "1544"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "V.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Papadimitrakopoulou",
                                        "ce:indexed-name": "Papadimitrakopoulou V.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han J.Y."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Papadimitrakopoulou VA, Mok TS, Han JY, et al. Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. Ann Oncol. 2020;31:1536-1544."
                    },
                    {
                        "ref-fulltext": "Soria, J.C., Ohe, Y., Vansteenkiste, J., et al. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med 378 (2018), 113\u2013125.",
                        "@reference-instance-id": "OB2BibRecID-949106172-857aff691967b402b61080a0f4dafa6a-17",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040652883",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "378"},
                                "pagerange": {
                                    "@first": "113",
                                    "@last": "125"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Soria",
                                        "ce:indexed-name": "Soria J.C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.",
                                        "@_fa": "true",
                                        "ce:surname": "Ohe",
                                        "ce:indexed-name": "Ohe Y."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Vansteenkiste",
                                        "ce:indexed-name": "Vansteenkiste J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Soria JC, Ohe Y, Vansteenkiste J, et al. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer. N Engl J Med. 2018;378:113-125."
                    },
                    {
                        "ref-fulltext": "European Medicines Agency. TAGRISSO® (osimertinib). Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/tagrisso-epar-product-information_en.pdf. (Accessed 21 March 2023)",
                        "@reference-instance-id": "OB2BibRecID-949106172-9e1ef75b794d51df146743ed2f7ed38c-18",
                        "@id": "18",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.ema.europa.eu/en/documents/product-information/tagrisso-epar-product-information_en.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "TAGRISSO® (osimertinib). Summary of product characteristics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85163293710",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 21 March 2023)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "European Medicines Agency",
                                "ce:indexed-name": "European Medicines Agency"
                            }}
                        },
                        "ce:source-text": "European Medicines Agency. TAGRISSO® (osimertinib). Summary of product characteristics. https://www.ema.europa.eu/en/documents/product-information/tagrisso-epar-product-information_en.pdf. Accessed March 21, 2023."
                    },
                    {
                        "ref-fulltext": "US Food and Drug Administration. TAGRISSO® (osimertinib). Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208065s025lbl.pdf. (Accessed 21 March 2023)",
                        "@reference-instance-id": "OB2BibRecID-949106172-4d3b6602d08cdd6fb73ce30d40109548-19",
                        "@id": "19",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208065s025lbl.pdf",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "TAGRISSO® (osimertinib). Highlights of prescribing information"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85163387100",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 21 March 2023)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "US Food and Drug Administration",
                                "ce:indexed-name": "US Food and Drug Administration"
                            }}
                        },
                        "ce:source-text": "US Food and Drug Administration. TAGRISSO® (osimertinib). Highlights of prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/208065s025lbl.pdf. Accessed March 21, 2023."
                    },
                    {
                        "ref-fulltext": "Majem, M., Goldman, J.W., John, T., et al. Health-related quality of life outcomes in patients with resected epidermal growth factor receptor-mutated non-small cell lung cancer who received adjuvant osimertinib in the phase III ADAURA trial. Clin Cancer Res 28 (2022), 2286\u20132296.",
                        "@reference-instance-id": "OB2BibRecID-949106172-b5256b2cfee1105be0c808c23f341315-20",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Health-related quality of life outcomes in patients with resected epidermal growth factor receptor-mutated non-small cell lung cancer who received adjuvant osimertinib in the phase III ADAURA trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85129128231",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "2286",
                                    "@last": "2296"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Majem",
                                        "ce:indexed-name": "Majem M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Goldman",
                                        "ce:indexed-name": "Goldman J.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "John",
                                        "ce:indexed-name": "John T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Majem M, Goldman JW, John T, et al. Health-related quality of life outcomes in patients with resected epidermal growth factor receptor-mutated non-small cell lung cancer who received adjuvant osimertinib in the phase III ADAURA trial. Clin Cancer Res. 2022;28:2286-2296."
                    },
                    {
                        "ref-fulltext": "Maruish, M., Kosinski, M., Bjorner, J., et al. User's Manual for the SF-36v2 Health Survey. 3rd ed, 2011, Quality Metric Inc, Lincoln, RI.",
                        "@reference-instance-id": "OB2BibRecID-949106172-187c525427ce3851b9ecfb067e2de8ba-21",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "User's Manual for the SF-36v2 Health Survey"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84866386186",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "3rd ed Quality Metric Inc Lincoln, RI",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Maruish",
                                        "ce:indexed-name": "Maruish M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kosinski",
                                        "ce:indexed-name": "Kosinski M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Bjorner",
                                        "ce:indexed-name": "Bjorner J."
                                    }
                                ],
                                "et-al": null
                            }
                        },
                        "ce:source-text": "Maruish M, Kosinski M, Bjorner J, et al. User's Manual for the SF-36v2 Health Survey. 3rd ed Lincoln, RI: Quality Metric Inc; 2011."
                    },
                    {
                        "ref-fulltext": "Postmus, P.E., Kerr, K.M., Oudkerk, M., et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 28:suppl 4 (2017), iv1\u2013iv21.",
                        "@reference-instance-id": "OB2BibRecID-949106172-68a673f8ca77d108625aa0384555f309-22",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85029726749",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "iv1",
                                    "@last": "iv21"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Postmus",
                                        "ce:indexed-name": "Postmus P.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kerr",
                                        "ce:indexed-name": "Kerr K.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Oudkerk",
                                        "ce:indexed-name": "Oudkerk M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Postmus PE, Kerr KM, Oudkerk M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl 4):iv1-iv21."
                    },
                    {
                        "ref-fulltext": "Kelly, K., Altorki, N.K., Eberhardt, W.E., et al. Adjuvant erlotinib versus placebo in patients with stage IB-IIIA non-small-cell lung cancer (RADIANT): a randomized, double-blind, phase III trial. J Clin Oncol 33 (2015), 4007\u20134014.",
                        "@reference-instance-id": "OB2BibRecID-949106172-6725719821697610b3dee29bf8e73f47-23",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Adjuvant erlotinib versus placebo in patients with stage IB-IIIA non-small-cell lung cancer (RADIANT): a randomized, double-blind, phase III trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84948384227",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "33"},
                                "pagerange": {
                                    "@first": "4007",
                                    "@last": "4014"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Kelly",
                                        "ce:indexed-name": "Kelly K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Altorki",
                                        "ce:indexed-name": "Altorki N.K."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "W.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Eberhardt",
                                        "ce:indexed-name": "Eberhardt W.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Kelly K, Altorki NK, Eberhardt WE, et al. Adjuvant erlotinib versus placebo in patients with stage IB-IIIA non-small-cell lung cancer (RADIANT): a randomized, double-blind, phase III trial. J Clin Oncol. 2015;33:4007-4014."
                    },
                    {
                        "ref-fulltext": "Tada, H., Mitsudomi, T., Misumi, T., et al. Randomized phase III study of gefitinib versus cisplatin plus vinorelbine for patients with resected stage II-IIIA non-small-cell lung cancer with EGFR mutation (IMPACT). J Clin Oncol 40 (2022), 231\u2013241.",
                        "@reference-instance-id": "OB2BibRecID-949106172-e3f732e0e940a62c9fff02ddea3bf564-24",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Randomized phase III study of gefitinib versus cisplatin plus vinorelbine for patients with resected stage II-IIIA non-small-cell lung cancer with EGFR mutation (IMPACT)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85123813049",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {
                                    "@first": "231",
                                    "@last": "241"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Tada",
                                        "ce:indexed-name": "Tada H."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Mitsudomi",
                                        "ce:indexed-name": "Mitsudomi T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Misumi",
                                        "ce:indexed-name": "Misumi T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Tada H, Mitsudomi T, Misumi T, et al. Randomized phase III study of gefitinib versus cisplatin plus vinorelbine for patients with resected stage II-IIIA non-small-cell lung cancer with EGFR mutation (IMPACT). J Clin Oncol. 2022;40:231-241."
                    },
                    {
                        "ref-fulltext": "Unger, J.M., Vaidya, R., Albain, K.S., et al. Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials. J Clin Oncol 40 (2022), 1474\u20131486.",
                        "@reference-instance-id": "OB2BibRecID-949106172-4c5abadafb2030d1af9d883327dea978-25",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2022"},
                            "ref-title": {"ref-titletext": "Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85129779260",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {
                                    "@first": "1474",
                                    "@last": "1486"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Unger",
                                        "ce:indexed-name": "Unger J.M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Vaidya",
                                        "ce:indexed-name": "Vaidya R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Albain",
                                        "ce:indexed-name": "Albain K.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Unger JM, Vaidya R, Albain KS, et al. Sex differences in risk of severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in cancer clinical trials. J Clin Oncol. 2022;40:1474-1486."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Cambridge",
            "@id": "60004219",
            "affilname": "AstraZeneca",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004219",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Guangzhou",
            "@id": "60069718",
            "affilname": "Guangdong Provincial People\u2019s Hospital of Southern Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069718",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60033129",
            "affilname": "Peter Maccallum Cancer Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033129",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60030442",
            "affilname": "Istituto Europeo di Oncologia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030442",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Suwon",
            "@id": "60029305",
            "affilname": "Ajou University School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029305",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60027817",
            "affilname": "Princess Margaret Cancer Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027817",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60026553",
            "affilname": "University of Melbourne",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Bologna",
            "@id": "60024574",
            "affilname": "IRCCS Azienda Ospedaliero-Universitaria di Bologna",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024574",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chicago",
            "@id": "60018691",
            "affilname": "Rush University Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018691",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New Haven",
            "@id": "60017994",
            "affilname": "Yale School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017994",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Yokohama",
            "@id": "60017631",
            "affilname": "Kanagawa Cancer Center Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017631",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Tainan",
            "@id": "60014982",
            "affilname": "National Cheng Kung University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014982",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Tianjin",
            "@id": "60011715",
            "affilname": "Tianjin Medical University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011715",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Kashiwa",
            "@id": "60010925",
            "affilname": "National Cancer Center Hospital East",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925",
            "affiliation-country": "Japan"
        },
        {
            "affiliation-city": "Shanghai",
            "@id": "60009860",
            "affilname": "Fudan University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009860",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Barcelona",
            "@id": "60009466",
            "affilname": "Hospital de La Santa Creu I Sant Pau",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009466",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Los Angeles",
            "@id": "60005247",
            "affilname": "David Geffen School of Medicine at UCLA",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005247",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Berlin",
            "@id": "112642958",
            "affilname": "Evangelische Lungenklinik Berlin-Buch",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112642958",
            "affiliation-country": "Germany"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85163304152",
        "dc:description": "Introduction: In ADAURA, adjuvant osimertinib significantly improved disease-free survival versus placebo in resected stage IB to IIIA EGFR-mutated NSCLC. We report in-depth analyses of three-year safety, tolerability, and health-related quality of life (HRQoL) from ADAURA. Methods: Patients were randomized 1:1 to osimertinib 80 mg or placebo once daily for up to 3 years. Safety assessments were performed at baseline, week 2, week 4, week 12, and every 12 weeks until treatment completion or discontinuation, and 28 days after treatment was stopped. The SF-36 survey measured HRQoL at baseline, week 12, week 24, and every 24 weeks until recurrence, treatment completion or discontinuation. Data cutoff: April 11, 2022. Results: Safety and HRQoL analysis sets: osimertinib, n = 337 and n = 339; placebo, n = 343 each. Median (range) total exposure duration was longer with osimertinib versus placebo: 35.8 (0\u201338) versus 25.1 (0\u201339) months. Most adverse events (AEs) were first reported within 12 months of starting treatment (osimertinib 97%, placebo 86%). AEs leading to dose reduction, interruption or discontinuation were reported in 12%, 27% and 13% respectively of patients with osimertinib; 1%, 13% and 3% with placebo. Stomatitis and diarrhea were the most common AEs leading to osimertinib dose reduction or interruption; interstitial lung disease was the most common leading to osimertinib discontinuation (per protocol). There were no differences in time to deterioration for SF-36 physical, mental component summaries between osimertinib and placebo. Conclusions: No new safety signals were reported and HRQoL was maintained with 3 years of adjuvant osimertinib treatment. Combined with significant efficacy benefit, these data further support adjuvant osimertinib in stage IB to IIIA EGFR-mutated NSCLC.",
        "pubmed-id": "37236398",
        "prism:coverDate": "2023-09-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85163304152",
        "dc:creator": {"author": [{
            "ce:given-name": "Thomas",
            "preferred-name": {
                "ce:given-name": "Thomas",
                "ce:initials": "T.",
                "ce:surname": "John",
                "ce:indexed-name": "John T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60033129",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033129"
                },
                {
                    "@id": "60026553",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553"
                }
            ],
            "ce:degrees": "M.B.B.S., PhD",
            "ce:surname": "John",
            "@auid": "8696243400",
            "author-url": "https://api.elsevier.com/content/author/author_id/8696243400",
            "ce:indexed-name": "John T."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85163304152"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85163304152&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85163304152&origin=inward"
            }
        ],
        "source-id": "6400153137",
        "pii": "S1556086423005749",
        "citedby-count": "1",
        "prism:volume": "18",
        "subtype": "ar",
        "dc:title": "Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial",
        "openaccess": "1",
        "prism:issn": "15561380 15560864",
        "publishercopyright": "© 2023 International Association for the Study of Lung Cancer",
        "prism:issueIdentifier": "9",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Thoracic Oncology",
        "prism:pageRange": "1209-1221",
        "prism:endingPage": "1221",
        "openaccessFlag": "true",
        "prism:doi": "10.1016/j.jtho.2023.05.015",
        "prism:startingPage": "1209",
        "dc:identifier": "SCOPUS_ID:85163304152",
        "dc:publisher": "Elsevier Inc."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Aniline Compounds",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Carcinoma, Non-Small-Cell Lung",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "ErbB Receptors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lung Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Mutation",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Protein Kinase Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Quality of Life",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Adjuvant"
        },
        {
            "@_fa": "true",
            "$": "EGFR"
        },
        {
            "@_fa": "true",
            "$": "Non\u2013small cell lung cancer"
        },
        {
            "@_fa": "true",
            "$": "Osimertinib"
        },
        {
            "@_fa": "true",
            "$": "Safety"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pulmonary and Respiratory Medicine",
            "@code": "2740",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Thomas",
            "preferred-name": {
                "ce:given-name": "Thomas",
                "ce:initials": "T.",
                "ce:surname": "John",
                "ce:indexed-name": "John T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60033129",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033129"
                },
                {
                    "@id": "60026553",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553"
                }
            ],
            "ce:degrees": "M.B.B.S., PhD",
            "ce:surname": "John",
            "@auid": "8696243400",
            "author-url": "https://api.elsevier.com/content/author/author_id/8696243400",
            "ce:indexed-name": "John T."
        },
        {
            "ce:given-name": "Christian",
            "preferred-name": {
                "ce:given-name": "Christian",
                "ce:initials": "C.",
                "ce:surname": "Grohé",
                "ce:indexed-name": "Grohé C."
            },
            "@seq": "2",
            "ce:initials": "C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "112642958",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/112642958"
            },
            "ce:degrees": "MD",
            "ce:surname": "Grohé",
            "@auid": "55981368600",
            "author-url": "https://api.elsevier.com/content/author/author_id/55981368600",
            "ce:indexed-name": "Grohe C."
        },
        {
            "ce:given-name": "Jonathan W.",
            "preferred-name": {
                "ce:given-name": "Jonathan W.",
                "ce:initials": "J.W.",
                "ce:surname": "Goldman",
                "ce:indexed-name": "Goldman J.W."
            },
            "@seq": "3",
            "ce:initials": "J.W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005247",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005247"
            },
            "ce:degrees": "MD",
            "ce:surname": "Goldman",
            "@auid": "55218010300",
            "author-url": "https://api.elsevier.com/content/author/author_id/55218010300",
            "ce:indexed-name": "Goldman J.W."
        },
        {
            "ce:given-name": "Frances A.",
            "preferred-name": {
                "ce:given-name": "Frances A.",
                "ce:initials": "F.A.",
                "ce:surname": "Shepherd",
                "ce:indexed-name": "Shepherd F.A."
            },
            "@seq": "4",
            "ce:initials": "F.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60027817",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027817"
            },
            "ce:degrees": "MD, FRCPC",
            "ce:surname": "Shepherd",
            "@auid": "7101805167",
            "author-url": "https://api.elsevier.com/content/author/author_id/7101805167",
            "ce:indexed-name": "Shepherd F.A."
        },
        {
            "ce:given-name": "Filippo",
            "preferred-name": {
                "ce:given-name": "Filippo",
                "ce:initials": "F.",
                "ce:surname": "de Marinis",
                "ce:indexed-name": "de Marinis F."
            },
            "@seq": "5",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60030442",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030442"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "de Marinis",
            "@auid": "56273853600",
            "author-url": "https://api.elsevier.com/content/author/author_id/56273853600",
            "ce:indexed-name": "de Marinis F."
        },
        {
            "ce:given-name": "Terufumi",
            "preferred-name": {
                "ce:given-name": "Terufumi",
                "ce:initials": "T.",
                "ce:surname": "Kato",
                "ce:indexed-name": "Kato T."
            },
            "@seq": "6",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017631",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017631"
            },
            "ce:degrees": "MD",
            "ce:surname": "Kato",
            "@auid": "35782069000",
            "author-url": "https://api.elsevier.com/content/author/author_id/35782069000",
            "ce:indexed-name": "Kato T."
        },
        {
            "ce:given-name": "Qun",
            "preferred-name": {
                "ce:given-name": "Qun",
                "ce:initials": "Q.",
                "ce:surname": "Wang",
                "ce:indexed-name": "Wang Q."
            },
            "@seq": "7",
            "ce:initials": "Q.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009860",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009860"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Wang",
            "@auid": "57003969300",
            "author-url": "https://api.elsevier.com/content/author/author_id/57003969300",
            "ce:indexed-name": "Wang Q."
        },
        {
            "ce:given-name": "Wu-Chou",
            "preferred-name": {
                "ce:given-name": "Wu Chou",
                "ce:initials": "W.C.",
                "ce:surname": "Su",
                "ce:indexed-name": "Su W.C."
            },
            "@seq": "8",
            "ce:initials": "W.-C.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60014982",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014982"
            },
            "ce:degrees": "MD",
            "ce:surname": "Su",
            "@auid": "57220849247",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220849247",
            "ce:indexed-name": "Su W.-C."
        },
        {
            "ce:given-name": "Jin Hyuk",
            "preferred-name": {
                "ce:given-name": "Jin Hyuk",
                "ce:initials": "J.H.",
                "ce:surname": "Choi",
                "ce:indexed-name": "Choi J.H."
            },
            "@seq": "9",
            "ce:initials": "J.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60029305",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029305"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Choi",
            "@auid": "58399117800",
            "author-url": "https://api.elsevier.com/content/author/author_id/58399117800",
            "ce:indexed-name": "Choi J.H."
        },
        {
            "ce:given-name": "Virote",
            "preferred-name": {
                "ce:given-name": "Virote",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "10",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "ce:given-name": "Barbara",
            "preferred-name": {
                "ce:given-name": "Barbara",
                "ce:initials": "B.",
                "ce:surname": "Melotti",
                "ce:indexed-name": "Melotti B."
            },
            "@seq": "11",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60024574",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60024574"
            },
            "ce:degrees": "MD",
            "ce:surname": "Melotti",
            "@auid": "6603480101",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603480101",
            "ce:indexed-name": "Melotti B."
        },
        {
            "ce:given-name": "Mary J.",
            "preferred-name": {
                "ce:given-name": "Mary J.",
                "ce:initials": "M.J.",
                "ce:surname": "Fidler",
                "ce:indexed-name": "Fidler M.J."
            },
            "@seq": "12",
            "ce:initials": "M.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018691",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018691"
            },
            "ce:degrees": "MD",
            "ce:surname": "Fidler",
            "@auid": "24072857000",
            "author-url": "https://api.elsevier.com/content/author/author_id/24072857000",
            "ce:indexed-name": "Fidler M.J."
        },
        {
            "ce:given-name": "Jun",
            "preferred-name": {
                "ce:given-name": "Jun",
                "ce:initials": "J.",
                "ce:surname": "Chen",
                "ce:indexed-name": "Chen J."
            },
            "@seq": "13",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60011715",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011715"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Chen",
            "@auid": "56214794800",
            "author-url": "https://api.elsevier.com/content/author/author_id/56214794800",
            "ce:indexed-name": "Chen J."
        },
        {
            "ce:given-name": "Muna",
            "preferred-name": {
                "ce:given-name": "Muna",
                "ce:initials": "M.",
                "ce:surname": "Albayaty",
                "ce:indexed-name": "Albayaty M."
            },
            "@seq": "14",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60004219",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004219"
            },
            "ce:degrees": "MbChB., FFPM, MSc",
            "ce:surname": "Albayaty",
            "@auid": "55779423400",
            "author-url": "https://api.elsevier.com/content/author/author_id/55779423400",
            "ce:indexed-name": "Albayaty M."
        },
        {
            "ce:given-name": "Marta",
            "preferred-name": {
                "ce:given-name": "Marta",
                "ce:initials": "M.",
                "ce:surname": "Stachowiak",
                "ce:indexed-name": "Stachowiak M."
            },
            "@seq": "15",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60004219",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004219"
            },
            "ce:degrees": "MPharm",
            "ce:surname": "Stachowiak",
            "@auid": "58165178800",
            "author-url": "https://api.elsevier.com/content/author/author_id/58165178800",
            "ce:indexed-name": "Stachowiak M."
        },
        {
            "ce:given-name": "Sarah",
            "preferred-name": {
                "ce:given-name": "Sarah",
                "ce:initials": "S.",
                "ce:surname": "Taggart",
                "ce:indexed-name": "Taggart S."
            },
            "@seq": "16",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60004219",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004219"
            },
            "ce:degrees": "Msci",
            "ce:surname": "Taggart",
            "@auid": "58393645600",
            "author-url": "https://api.elsevier.com/content/author/author_id/58393645600",
            "ce:indexed-name": "Taggart S."
        },
        {
            "ce:given-name": "Yi-Long",
            "preferred-name": {
                "ce:given-name": "Yi Long",
                "ce:initials": "Y.L.",
                "ce:surname": "Wu",
                "ce:indexed-name": "Wu Y.L."
            },
            "@seq": "17",
            "ce:initials": "Y.-L.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60069718",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60069718"
            },
            "ce:degrees": "MD",
            "ce:surname": "Wu",
            "@auid": "55569782000",
            "author-url": "https://api.elsevier.com/content/author/author_id/55569782000",
            "ce:indexed-name": "Wu Y.-L."
        },
        {
            "ce:given-name": "Masahiro",
            "preferred-name": {
                "ce:given-name": "Masahiro",
                "ce:initials": "M.",
                "ce:surname": "Tsuboi",
                "ce:indexed-name": "Tsuboi M."
            },
            "@seq": "18",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60010925",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60010925"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Tsuboi",
            "@auid": "55450411000",
            "author-url": "https://api.elsevier.com/content/author/author_id/55450411000",
            "ce:indexed-name": "Tsuboi M."
        },
        {
            "ce:given-name": "Roy S.",
            "preferred-name": {
                "ce:given-name": "Roy S.",
                "ce:initials": "R.S.",
                "ce:surname": "Herbst",
                "ce:indexed-name": "Herbst R.S."
            },
            "@seq": "19",
            "ce:initials": "R.S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60017994",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017994"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Herbst",
            "@auid": "7102823077",
            "author-url": "https://api.elsevier.com/content/author/author_id/7102823077",
            "ce:indexed-name": "Herbst R.S."
        },
        {
            "ce:given-name": "Margarita",
            "preferred-name": {
                "ce:given-name": "Margarita",
                "ce:initials": "M.",
                "ce:surname": "Majem",
                "ce:indexed-name": "Majem M."
            },
            "@seq": "20",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60009466",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009466"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Majem",
            "@auid": "24587678300",
            "author-url": "https://api.elsevier.com/content/author/author_id/24587678300",
            "ce:indexed-name": "Majem M."
        }
    ]}
}}